The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review

References

• Loeffler JS, Patchell RA, Sawaya R. Treatment of metastatic cancer. In: Cancer: Principles and Practice of Oncology (5th Edition). Devita VT, Hellman S, Rosenburg SA (Eds). Lippincott–Raven Publishers, PA, USA, 2523–2536 (1997).
   Google Scholar
• Cairncross JG, Kim JH, Posner JB. Radiation therapy for brain metastases. Ann. Neurol.7(6), 529–541 (1980).
   PubMed Web of Science ®Google Scholar
• Posner JB: Management of central nervous system metastases. Semin. Oncol.4(1), 81–91 (1977).
   PubMed Web of Science ®Google Scholar
• Chao JH, Phillips R, Nickson JJ. Roentgen-ray therapy of cerebral metastases. Cancer7(4), 682–689 (1954).
   PubMed Web of Science ®Google Scholar
• Zimm S, Wampler GL, Stablein D et al. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer48(2), 384–394 (1981).
   PubMed Web of Science ®Google Scholar
• Mor V, Laliberte L, Morris JN et al. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer53(9), 2002–2007 (1984).
   PubMed Web of Science ®Google Scholar
• Locke DE, Decker PA, Sloan JA et al. Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J. Pain. Symptom. Manage34(6), 628–638 (2007).
   PubMed Web of Science ®Google Scholar
• Taphoorn MJ, Claassens L, Aaronson NK et al. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur. J. Cancer46(6), 1033–1040 (2010).
   PubMed Web of Science ®Google Scholar
• Groenvold M, Petersen MA, Aaronson NK et al. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur. J. Cancer42(1), 55–64 (2006).
   PubMed Web of Science ®Google Scholar
• Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur. J. Cancer33(7), 1025–1030 (1997).
   PubMed Web of Science ®Google Scholar
• Gerrard GE, Prestwich RJ, Edwards A et al. Investigating the palliative efficacy of whole-brain radiotherapy for patients with multiple-brain metastases and poor prognostic features. Clin. Oncol.15(7), 422–428 (2003).
   Google Scholar
• Roos DE, Wirth A, Burmeister BH et al. Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized trans-tasman radiation oncology group trial (TROG 98.05). Radiother. Oncol.80(3), 318–322 (2006).
   PubMed Web of Science ®Google Scholar
• Slotman BJ, Mauer ME, Bottomley A et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC radiation oncology and lung cancer groups. J. Clin. Oncol.27(1), 78–84 (2009).
   PubMed Web of Science ®Google Scholar
• Slotman B, Faivre-Finn C, Kramer G et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N. Engl. J. Med.357(7), 664–672 (2007).
   PubMed Web of Science ®Google Scholar
• Pace A, Parisi C, Di Lelio M et al. Home rehabilitation for brain tumor patients. J. Exp. Clin. Cancer Res.26(3), 297–300 (2007).
   PubMed Web of Science ®Google Scholar
• Muacevic A, Wowra B, Siefert A et al. Microsurgery plus whole brain irradiation versus gamma knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre Phase III trial. J. Neurooncol.87(3), 299–307 (2008).
   PubMed Web of Science ®Google Scholar
• Pan HC, Sun MH, Chen CC et al. Neuroimaging and quality-of-life outcomes in patients with brain metastasis and peritumoral edema who undergo gamma knife surgery. J. Neurosurg.109(Suppl.), 90–98 (2008).
   PubMed Web of Science ®Google Scholar
• Neuhaus T, Ko Y, Muller RP et al. A Phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer. Br. J. Cancer100(2), 291–297 (2009).
   PubMed Web of Science ®Google Scholar
• Steinmann D, Schafer C, van Oorschot B et al. Effects of radiotherapy for brain metastases on quality of life (QoL). prospective pilot study of the DEGRO QoL working party. Strahlenther. Onkol.185(3), 190–197 (2009).
   PubMedGoogle Scholar
• Wolfson AH, Bae K, Komaki R et al. Primary analysis of a Phase II randomized trial radiation therapy oncology group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys.81(1), 77–84 (2010).
   PubMedGoogle Scholar
• Le Pechoux C, Laplanche A, Faivre-Finn C et al. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup Phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann. Oncol.22(5), 1154–1163 (2011).
   PubMedGoogle Scholar
• Soffietti R, Mueller RP, Abacioglu MU et al. Quality-of-life results of an EORTC phase III randomized trial of adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases of solid tumors. J. Clin. Oncol.28(Suppl. 15), (Abstract 9036) (2010).
   Google Scholar
• Sun A, Bae K, Gore EM et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J. Clin. Oncol.29(3), 279–286 (2011).
   PubMed Web of Science ®Google Scholar
• Ahlner-Elmqvist M, Bjordal K, Jordhoy MS et al. Characteristics and implications of attrition in health-related quality of life studies in palliative care. Palliat. Med.23(5), 432–440 (2009).
   PubMed Web of Science ®Google Scholar
• Chow E, Davis L, Holden L et al. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases. J.Pain Symptom Manage30(1), 18–23 (2005).
   PubMed Web of Science ®Google Scholar
• Bradley N, Davis L, Chow E. Symptom distress in patients attending an outpatient palliative radiotherapy clinic. J. Pain Symptom Manage.30(2), 123–131 (2005).
   PubMed Web of Science ®Google Scholar
• Zeng L, Chow E, Zhang L et al. Comparison of pain response and functional interference outcomes between spinal and non-spinal bone metastases treated with palliative radiotherapy. Support. Care Cancer doi:10.1007/s00520-011-1144-6 (2011) (Epub ahead of print).
   Google Scholar
• Bradley NM, Chow E, Tsao MN et al. Reasons for poor accrual in palliative radiation therapy research studies. Support Cancer Ther.3(2), 110–119 (2006).
   PubMedGoogle Scholar
• Zeng L, Sahgal A, Zhang L et al. Patterns of pain and functional improvement in patients with bone metastases after conventional external beam radiotherapy and a telephone validation study. Pain Res. Treat. doi:10.1155/2011/601720 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Sneeuw KC, Aaronson NK, Osoba D et al. The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med. Care35(5), 490–506 (1997).
   PubMed Web of Science ®Google Scholar
• Tang ST, McCorkle R. Use of family proxies in quality of life research for cancer patients at the end of life: a literature review. Cancer Invest.20(7–8), 1086–1104 (2002).
   PubMed Web of Science ®Google Scholar
• Giesinger JM, Golser M, Erharter A et al. Do neurooncological patients and their significant others agree on quality of life ratings? Health Qual. Life Outcomes7, 87 (2009).
   PubMed Web of Science ®Google Scholar
• Li J, Bentzen SM, Li J et al. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int. J. Radiat. Oncol. Biol. Phys.71(1), 64–70 (2008).
   PubMed Web of Science ®Google Scholar
• Vardy J, Chiew KS, Galica J et al. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br. J. Cancer94(7), 1011–1015 (2006).
   PubMed Web of Science ®Google Scholar
• Chow E, Wu JS, Hoskin P et al. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother. Oncol.64(3), 275–280 (2002).
   PubMed Web of Science ®Google Scholar
• Glantz MJ, Cole BF, Forsyth PA et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology54(10), 1886–1893 (2000).
   PubMed Web of Science ®Google Scholar
• Maringwa J, Quinten C, King M et al. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann. Oncol.22(9), 2107–2112 (2011).
   PubMed Web of Science ®Google Scholar
• Cella D, Hahn EA, Dineen K.Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual. Life Res.11(3), 207–221 (2002).
   PubMed Web of Science ®Google Scholar